Heron Therapeutics, Inc.

HRTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$0.51+3.06%

2026-08-03

Financials

Valuation Metrics

Heron Therapeutics, Inc.'s Market Cap is $97M. At end of 2025 it was $217M. Ranked #3079 of 3,112 in US market (top 99%), #1414 of 1,445 on NASDAQ (top 98%), #266 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 99%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$97M	US#3,079/3,112 Sec#266/269
Revenue	$151M	US#2,730/3,112 Sec#117/269
Net Income	$-31M	US—/3,112 Sec—/269
Total Assets	$246M	US#2,946/3,112 Sec#236/269
Net Assets	$9M	US#2,997/3,112 Sec#260/269
Value
P/B	10.59x	US#2,634/3,112 Sec#206/269
P/S	0.64x	US#380/3,112 Sec#7/269
FCF Yield	-21.55%	US—/3,112 Sec—/269
Profitability
ROA	-12.57%	US#2,687/3,112 Sec#108/269
Op. Margin	-6.94%	US#2,592/3,112 Sec#93/269
Revenue Growth	-10.78%	US#2,680/3,112 Sec#148/269
Earnings Growth	-407.82%	US#2,310/3,112 Sec#90/269
Financial Health
Debt Ratio	2594.71%	US#2,930/3,112 Sec#258/269
Total Debt	$142M	US#2,296/3,112 Sec#105/269
FCF	$-21M	US#2,375/3,112 Sec#94/269
Cash	$26M	US#2,803/3,112 Sec#254/269
Current Ratio	2.53x	US#982/3,112 Sec#209/269
Performance
1Y Return	-69.74%	US#3,092/3,112 Sec#265/269
1M Return	16.65%	US#226/3,112 Sec#10/269
From 52W High	-72.80%	US#3,042/3,112 Sec#257/269
1Y MDD	-82.87%	US#3,067/3,112 Sec#264/269
Trading
Volume	1,497,951 shares	US#1,121/3,112 Sec#105/269
Trading Value	$763310.00	US#3,047/3,112 Sec#261/269
Per Share
EPS	$-0.12	US—/3,112 Sec—/269
BPS	$0.09	US#2,717/3,112 Sec#231/269